Clinical Trials Directory

Trials / Unknown

UnknownNCT03966001

Cesarean Scar Defect Formation After First Cesarean Section.

Formation of the Cesarean Scar Defect After the First Cesarean. A Prospective Observational Study of Planned Versus Emergency Cesarean Sections

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Uludag University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study is a prospective observational study which will monitor how cesarean section in the first pregnancy will develop a cesarean scar defect. Patients with planned cesarean section in their first pregnancy and those with an emergency cesarean section will be monitored for one year.

Detailed description

Cesarean scar defects, which may develop after cesarean deliveries, are associated with menstrual bleeding problems, infertility, and poor obstetric outcomes. No matter how excellent and standard surgical technique is applied, scar defects may develop after cesarean section. However, when cesarean operation decision is taken, the existing operational conditions can affect the formation of cesarean scar defect in the future. Although the surgical technique is the same, a planned cesarean operation and an emergency cesarean section may differ for a future cesarean scar defect that may develop in the future.

Conditions

Interventions

TypeNameDescription
OTHERTransvaginal sonography at six months after cesarean sectionIn the sixth month after cesarean section, Women in both groups will undergo a detailed pelvic examination and transvaginal ultrasonographic evaluation for the cesarean scar defect.
OTHERTransvaginal sonography at twelve months after cesarean sectionIn the twelfth month after cesarean section, Women in both groups will undergo a detailed pelvic examination and transvaginal ultrasonographic evaluation for the cesarean scar defect.

Timeline

Start date
2019-06-25
Primary completion
2020-06-01
Completion
2020-12-15
First posted
2019-05-29
Last updated
2019-06-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03966001. Inclusion in this directory is not an endorsement.